Onderneming Biostar Pharmaceuticals Inc Nasdaq
Aandelen
US0906782026
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2015 | Gewicht | 2016 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 27 | 100,0 % | 2 | 100,0 % | -91,21% |
Verkoop per regio
USD in miljoen | 2015 | Gewicht | 2016 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 27 | 100,0 % | 2 | 100,0 % | -91,21% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Rong Hua Wang
CEO | Chief Executive Officer | 69 | 27-03-07 |
Xiaojuan Zhai
DFI | Director of Finance/CFO | - | 05-02-17 |
Zheng Hong Wang
COO | Chief Operating Officer | 43 | 01-03-12 |
Gong Shuang
ADM | Chief Administrative Officer | 54 | 01-01-07 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rong Hua Wang
CEO | Chief Executive Officer | 69 | 27-03-07 |
Hai Peng Wu
BRD | Director/Board Member | 66 | 01-07-07 |
Zhan Xiang Ma
BRD | Director/Board Member | - | 29-01-18 |
Hui ping Liao
BRD | Director/Board Member | - | 29-01-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 637 188 | 2 637 188 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
BioStar Pharmaceuticals, Inc.
No. 588 Shiji Xi Avenue
712046, Xianyang
+86 29 3368 6638
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,37% | 588 mld. | |
-2,82% | 364 mld. | |
+20,40% | 326 mld. | |
+5,45% | 285 mld. | |
+14,83% | 239 mld. | |
+9,93% | 210 mld. | |
-6,95% | 200 mld. | |
+10,96% | 167 mld. | |
+0,03% | 161 mld. |
- Beurs
- Aandelen
- Koers BSPM
- Koers
- Onderneming Biostar Pharmaceuticals Inc